Literature DB >> 22363911

A surgically treated case of chronic necrotizing aspergillosis with pleural invasion.

Kyung-Hak Lee1, Se Min Ryu, Sung-Min Park, Hyun Seok Park, Kang Hoon Lee, Seong-Joon Cho.   

Abstract

Aspergillus is a ubiquitous fungus and can cause many levels of disease severity. Chronic necrotizing aspergillosis is a rare disease and few cases have been reported in Korea. We experienced a case of pleural aspergillosis that was treated successfully with medical and surgical interventions. The 52-year-old man who was diagnosed with chronic necrotizing pulmonary aspergillosis underwent surgical treatment including a lobectomy, decortication, and myoplasty. The patient was also medically treated with amphotericin B followed by voriconazole. Pleural irrigation with amphotericin B was also performed. A multi-dimensional approach should be considered for treating chronic necrotizing pulmonary aspergillosis.

Entities:  

Keywords:  Aspergillosis; Decortication; Fungal infection; Lung surgery; Pleural disease

Year:  2012        PMID: 22363911      PMCID: PMC3283787          DOI: 10.5090/kjtcs.2012.45.1.56

Source DB:  PubMed          Journal:  Korean J Thorac Cardiovasc Surg        ISSN: 2233-601X


  5 in total

Review 1.  The clinical spectrum of pulmonary aspergillosis.

Authors:  Ayman O Soubani; Pranatharthi H Chandrasekar
Journal:  Chest       Date:  2002-06       Impact factor: 9.410

2.  Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.

Authors:  Thomas J Walsh; Elias J Anaissie; David W Denning; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; Brahm H Segal; William J Steinbach; David A Stevens; Jo-Anne van Burik; John R Wingard; Thomas F Patterson
Journal:  Clin Infect Dis       Date:  2008-02-01       Impact factor: 9.079

Review 3.  Voriconazole: a broad-spectrum triazole for the treatment of invasive fungal infections.

Authors:  Jane A Cecil; Richard P Wenzel
Journal:  Expert Rev Hematol       Date:  2009-06       Impact factor: 2.929

4.  Treatment of complicated pulmonary aspergillomas with cavernostomy and muscle flap: interest of concomitant limited thoracoplasty.

Authors:  Renaud Grima; Athanase Krassas; Patrick Bagan; Alain Badia; Françoise Le Pimpec Barthes; Marc Riquet
Journal:  Eur J Cardiothorac Surg       Date:  2009-11       Impact factor: 4.191

5.  Intracavitary amphotereicin B in the treatment of symptomatic pulmonary aspergillomas.

Authors:  J L Hargis; R C Bone; J Stewart; N Rector; F C Hiller
Journal:  Am J Med       Date:  1980-03       Impact factor: 4.965

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.